Article

The Problem with the Cancer ‘Battle’

The terminology surrounding the cancer journey is often associated with a “battle” and can misconstrue the experience of treatment.

Language is an important tool when it comes to living with cancer. The terminology used when referring to an individual’s experience with the disease can incite a range of emotions and can often be misconstrued.

Dr. Mark Lewis, of Intermountain Healthcare, is also a survivor. In a recent interview with CURE®, Lewis discussed why the use of the word “battle” can be polarizing when referring to someone’s cancer journey, and why sometimes the idea of opting to forego treatment is the bravest decision of all.

Transcription:

One of the problems I have with language around cancer is, whether patients choose or not, there's often a lot of talk about ‘battle.’

In fact, in almost every obituary I saw about Chadwick Boseman mentioned him battling cancer. You know, if you accept the fighting metaphor, that's great, but it's not for everybody. And what I don't like about it is it implies some lack of courage, or spirit, when patients either die, or, quite reasonably sometimes, if they choose not to pursue chemotherapy.

Sometimes I think the bravest decision I see is someone who, against the recommendation and pressure from their family, says, ‘You know what, I've listened to you, doc, I've heard about the risks and benefits. I just want to live my life, however long that's going to be, and I want to maximize its quality.’

That, in itself, is a very courageous decision, in my opinion.

Related Videos
Image of Dr. Braun.
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Michael Bogenschutz
Photo credit: Max Mumby/Indigo via Getty Images
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Stephanie Alice Baker
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Related Content